Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blastsLI LI; GIANNOPOULOS, Krzysztof; SCHMITT, Michael et al.International journal of oncology. 2006, Vol 28, Num 4, pp 855-861, issn 1019-6439, 7 p.Article

mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapiesGREINER, Jochen; RINGHOFFER, Mark; TANIGUCHI, Masanori et al.International journal of cancer. 2004, Vol 108, Num 5, pp 704-711, issn 0020-7136, 8 p.Article

Mutated regions of nucleophosmin 1 elicit both CD4⁺ and CD8⁺ T-cell responses in patients with acute myeloid leukemiaGREINER, Jochen; ONO, Yoko; SCHMITT, Michael et al.Blood. 2012, Vol 120, Num 6, pp 1282-1289, issn 0006-4971, 8 p.Article

CD34⁺ cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patientsRINGHOFFER, Mark; WIESNETH, Markus; DÖHNER, Hartmut et al.British journal of haematology. 2004, Vol 126, Num 4, pp 527-535, issn 0007-1048, 9 p.Article

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantationSCHMITT, Anita; TONN, Torsten; GREINER, Jochen et al.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 3, pp 591-599, issn 0041-1132, 9 p.Article

Cytomegalovirus vaccination of leukemia and lymphoma patients after allogeneic stem cell transplantation ― Validation of a peptide vaccineSCHMITT, Anita; BECHTER, Clemens; JUNXIA YAO et al.Journal of immunological methods. 2009, Vol 343, Num 2, pp 140-147, issn 0022-1759, 8 p.Article

The receptor for hyaluronic acid-mediated motility induces specific CD8⁺ T cell response in healthy donors and patients with chronic myeloid leukemia after allogeneic stem cell transplantationCHENI, Jinfei; SCHMITT, Anita; BUNJES, Donald et al.International journal of oncology. 2007, Vol 30, Num 5, pp 1119-1127, issn 1019-6439, 9 p.Article

High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myelomaGREINER, Jochen; SCHMITT, Anita; DÖHNER, Hartmut et al.Haematologica (Roma). 2010, Vol 95, Num 7, pp 1191-1197, issn 0390-6078, 7 p.Article

Dasatinib inhibits the proliferation and function of CD4⁺CD25⁺ regulatory T cellsFEI FEI; YINGZHE YU; SCHMITT, Anita et al.British journal of haematology. 2009, Vol 144, Num 2, pp 195-205, issn 0007-1048, 11 p.Article

The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8⁺ T cell responsesSCHMITT, Anita; BARTH, Thomas F. E; RIECHELMANN, Herbert et al.International journal of oncology. 2009, Vol 34, Num 3, pp 629-639, issn 1019-6439, 11 p.Article

Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemiaSCHMITT, Anita; LI LI; GIANNOPOULOS, Krzysztof et al.Transfusion (Philadelphia, PA). 2008, Vol 48, Num 5, pp 861-870, issn 0041-1132, 10 p.Article

Imatinib impairs the proliferation and function of CD4⁺CD25⁺ regulatory T cells in a dose-dependent mannerCHEW, Jinfei; SCHMITT, Anita; GIANNOPOULOS, Krzysztof et al.International journal of oncology. 2007, Vol 31, Num 5, pp 1133-1139, issn 1019-6439, 7 p.Article